Presentation is loading. Please wait.

Presentation is loading. Please wait.

Facilitating the Design of Fluorinated Drugs

Similar presentations


Presentation on theme: "Facilitating the Design of Fluorinated Drugs"— Presentation transcript:

1 Facilitating the Design of Fluorinated Drugs
Klaus Müller, Hans-Joachim Böhm  Chemistry & Biology  Volume 16, Issue 11, Pages (November 2009) DOI: /j.chembiol Copyright © 2009 Elsevier Ltd Terms and Conditions

2 Figure 1 Chemical Structure of the Ligand tBuBrettPhos
This ligand was used in the studies by Watson et al. (2009). Chemistry & Biology  , DOI: ( /j.chembiol ) Copyright © 2009 Elsevier Ltd Terms and Conditions

3 Figure 2 Typical Reaction Scheme for the Synthetic Method Developed by Watson et al. (2009). Key advancements are the use of CsF as a source of fluorine and the biaryl monophospine tBuBrettPhos as a hydrophobic Pd-ligand for the regiospecific aryl fluorination by reductive elimination from ary-tBuBrettPhos-Pd(II)-F intermediates. Chemistry & Biology  , DOI: ( /j.chembiol ) Copyright © 2009 Elsevier Ltd Terms and Conditions


Download ppt "Facilitating the Design of Fluorinated Drugs"

Similar presentations


Ads by Google